T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
2751
DELISTED
First Foundation Inc
FFWM
| $152K | ﹤0.01% |
24,459
+3,885
| +19% | +$28K |
|
2752
Codexis
CDXS
$175M
| $151K | ﹤0.01% |
31,552
+8,832
| +39% | +$36.4K |
|
2753
Porch Group
PRCH
$1.92B
| $151K | ﹤0.01% |
30,524
+5,557
| +22% | +$17.8K |
|
2754
Senseonics Holdings Inc
SENS
$409M
| $151K | ﹤0.01% |
14,445
| – | – |
|
2755
Fossil Group
FOSL
$330M
| $149K | ﹤0.01% |
88,900
| – | – |
|
2756
Chegg
CHGG
$89.3M
| $148K | ﹤0.01% |
91,333
-9,864
| -10% | -$18.2K |
|
2757
4D Molecular Therapeutics
FDMT
$609M
| $148K | ﹤0.01% |
26,546
-3,989
| -13% | -$31.3K |
|
|
SKYT
2758
DELISTED
SkyWater Technology
SKYT
| $147K | ﹤0.01% |
+10,587
| New | +$105K |
|
2759
Boston Omaha
BOC
$431M
| $146K | ﹤0.01% |
+10,226
| New | +$152K |
|
2760
Precigen
PGEN
$2.32B
| $146K | ﹤0.01% |
130,266
-39,235
| -23% | -$33.5K |
|
2761
ImmunityBio
IBRX
$8.11B
| $145K | ﹤0.01% |
56,288
-18,959
| -25% | -$79K |
|
2762
Mineralys Therapeutics
MLYS
$2.31B
| $145K | ﹤0.01% |
+11,715
| New | +$153K |
|
2763
Virgin Galactic
SPCE
$475M
| $144K | ﹤0.01% |
24,430
-8,229
| -25% | -$54.8K |
|
2764
VanEck Vietnam ETF
VNM
$506M
| $143K | ﹤0.01% |
12,446
-5,124
| -29% | -$61.1K |
|
2765
Butterfly Network
BFLY
$2.36B
| $142K | ﹤0.01% |
45,300
-38,100
| -46% | -$99.2K |
|
2766
Treace Medical Concepts
TMCI
$293M
| $142K | ﹤0.01% |
19,056
+3,452
| +22% | +$23.1K |
|
2767
Citizens
CIA
$198M
| $140K | ﹤0.01% |
34,900
| – | – |
|
2768
McEwen Inc
MUX
$1.14B
| $140K | ﹤0.01% |
17,900
| – | – |
|
2769
Entravision Communication
EVC
$820M
| $139K | ﹤0.01% |
59,128
+5,931
| +11% | +$13.9K |
|
2770
C4 Therapeutics
CCCC
$502M
| $138K | ﹤0.01% |
38,143
-353,861
| -90% | -$1.76M |
|
2771
GrowGeneration
GRWG
$108M
| $137K | ﹤0.01% |
80,998
+9,613
| +13% | +$18.4K |
|
2772
Luxfer Holdings
LXFR
$457M
| $137K | ﹤0.01% |
+10,414
| New | +$142K |
|
|
CTV
2773
DELISTED
Innovid Corp.
CTV
| $137K | ﹤0.01% |
44,179
+9,968
| +29% | +$23.5K |
|
2774
OmniAb
OABI
$499M
| $136K | ﹤0.01% |
38,217
+7,950
| +26% | +$31.5K |
|
2775
Pagaya Technologies
PGY
$1.79B
| $136K | ﹤0.01% |
14,552
-1,227
| -8% | -$13K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.